AstraZeneca ' s Imfinzi gets NICE nod for lung cancer

The National Institute for Health and Care Excellence (NICE) said it would cover AstraZeneca ' s Imfinzi via the Cancer Drugs Fund, for the treatment of certain patients with non-small-cell lung cancer.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news